Template:Atrial fibrillation: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(8 intermediate revisions by 5 users not shown) | |||
Line 21: | Line 21: | ||
! | ! | ||
[[Atrial fibrillation overview|Overview]] | [[Atrial fibrillation overview|Overview]] | ||
|- | |||
! | |||
|- bgcolor="Pink" | |||
! | |||
[[Atrial fibrillation historical perspective|Historical Perspective]] | |||
|- | |- | ||
! | ! | ||
Line 82: | Line 88: | ||
: [[Atrial fibrillation pulmonary diseases|Pulmonary Diseases]] | : [[Atrial fibrillation pulmonary diseases|Pulmonary Diseases]] | ||
: [[Atrial fibrillation pregnancy|Pregnancy]] | : [[Atrial fibrillation pregnancy|Pregnancy]] | ||
: [[Atrial fibrillation medical therapy in patients presenting with ACS and/or PCI or valve intervention|ACS and/or PCI or valve intervention]] | |||
: [[Congestive heart failure treatment of patients who have concomitant disorders|Heart failure]] | |||
|- | |- | ||
! | ! | ||
Line 146: | Line 154: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Atrial fibrillation rate control|Rate and Rhythm Control]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
Line 166: | Line 178: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
Line 187: | Line 193: | ||
: [[Atrial fibrillation cardiac surgery|Cardiac Surgery]] | : [[Atrial fibrillation cardiac surgery|Cardiac Surgery]] | ||
|- | |- | ||
|- bgcolor="PaleTurquoise" | |||
! | ! | ||
[[Atrial fibrillation specific patient groups|Specific Patient Groups]] | |||
|- | |||
! | |||
! | |||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Atrial fibrillation primary prevention|Primary Prevention]] | [[Atrial fibrillation primary prevention|Primary Prevention]] | ||
|- | |- | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
Line 199: | Line 211: | ||
[[Atrial fibrillation secondary prevention|Secondary Prevention]] | [[Atrial fibrillation secondary prevention|Secondary Prevention]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Atrial fibrillation | [[Atrial fibrillation supportive trial data|Supportive Trial Data]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Atrial fibrillation | [[Atrial fibrillation cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | ||
|- | |- | ||
! | ! |
Latest revision as of 16:01, 22 July 2021
Atrial Fibrillation Microchapters | |
Special Groups | |
---|---|
Diagnosis | |
Treatment | |
Cardioversion | |
Anticoagulation | |
Surgery | |
Case Studies | |
Atrial fibrillation On the Web | |